{"@id":"https://bioecon.ru/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","json":"https://en.bioecon.ru/api/v1/technology/immunosuppressant-apis-cyclosporin-tacrolimus/index.json"},"id":"immunosuppressant-apis-cyclosporin-tacrolimus","industries":[],"lang":"en","links":{"suppliers":["https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/bontac-bio-engineering-co-ltd/","https://bioecon.ru/companies/sumitomo-chemical/","https://bioecon.ru/companies/fufeng-group/","https://bioecon.ru/companies/hydropars-industrial-group/","https://bioecon.ru/companies/klk-oleo/","https://bioecon.ru/companies/aum-enzymes-infinita-biotech/","https://bioecon.ru/companies/enzymaster/","https://bioecon.ru/companies/pow-bio/"]},"maturity":8,"name":"Immunosuppressant APIs (Cyclosporin A and Tacrolimus)","regions":["us","cn","eu","ru"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-15","entity":"ncbi.nlm.nih.gov","kind":"research","urls":["https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905321/"]},{"date":"2026-11-15","entity":"sciencedirect.com","kind":"research","urls":["https://doi.org/10.1016/j.biotechadv.2023.108250"]}],"stages":[{"n":1,"title":null},{"n":2,"title":null},{"n":3,"title":null},{"n":4,"title":null}],"summary":"Industrial biomanufacturing of high-purity immunosuppressant apis (cyclosporin a and tacrolimus) utilizing engineered microbial fermentation or biocatalytic enzyme cascades. Fermentation-class immunosuppressant APIs: cyclosporin A (*Tolypocladium inflatum*), tacrolimus (*Streptomyces tsukubaensis*), sirolimus (*S. hygroscopicus*), m.","url":"/technology/immunosuppressant-apis-cyclosporin-tacrolimus/","verified":"2026-11-15"}